Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery Disease and Diabetes Mellitus

다국어 초록 (Multilingual Abstract)

Background and Objectives: Thrombospondin-1 (TSP-1) is associated with atherosclerosis in animals with diabetes mellitus (DM). But, no study has investigated the role of TSP-1 in human atherosclerosis. This study investigated the relationship among plasma TSP-1 concentration,DM, and coronary artery disease (CAD).
Subjects and Methods: The study involved 374 consecutive subjects with suspected CAD, who had undergone coronary angiography to evaluate effort angina. Patients were divided into four groups as follows: DM(-) and CAD(-), DM(-) and CAD(+), DM(+) and CAD(-), and DM (+) and CAD(+).
Results: We found that plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) (n=103) than those in other patients (n=271) (p<0.01). A multivariate analysis showed that male gender {odds ratio (OR), 2.728; 95% confidence interval (CI), 1.035-7.187}, high density lipoprotein-cholesterol (OR, 0.925; 95% CI, 0.874-0.980), glycated hemoglobin (OR, 1.373; 95% CI, 1.037-1.817), and plasma TSP-1(OR, 1.004; 95% CI, 1.000-1.008) levels were independently associated with the presence of CAD in patients with DM.
Conclusion: Plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) than those in other patients, and plasma TSP-1 levels were independently associated with the presence of CAD in patients with DM. These findings show a possible link between human plasma TSP-1 concentration and CAD in patients with DM.

참고문헌 (Reference)

1 Adams JC, "Thrombospondins: multifunctional regulators of cell interactions" 17 : 25-51, 2001

2 Yevdokimova N, "Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose" 12 : 703-712, 2001

3 Nör JE, "Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesisby activating the caspase death pathway" 37 : 209-218, 2000

4 Tada H, "Thrombospondin modulates adhesion, proliferation and production of extracellular matrix in mesangial cells" 177 : 293-302, 1995

5 Chobanian AV, "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report" 289 : 2560-2572, 2003

6 Agah A, "The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice" 161 : 831-839, 2002

7 McGillicuddy FC, "TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells" 44 : 469-475, 2006

8 Murphy M, "Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells" 274 : 5830-5834, 1999

9 Topol EJ, "Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction" 104 : 2641-2644, 2001

10 "Report of the Expert Committee on the diagnosis and classification of diabetes mellitus" 20 : 1183-1197, 1997

11 Kirma C, "Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease" 71 : 698-702, 2007

12 Stenina OI, "Regulation of vascular genes by glucose" 11 : 2367-2381, 2005

13 Ren B, "Regulation of tumor angiogenesis by thrombospondin-1" 1765 : 178-188, 2006

14 Yamada Y, "Prediction of the risk of myocardial infarction from polymorphisms in candidate genes" 347 : 1916-1923, 2002

15 Selvin E, "Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus" 141 : 421-431, 2004

16 Hsu SC, "Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1" 56 : 5684-5691, 1996

17 Carlson CB, "Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability" 283 : 20069-20076, 2008

18 Isenberg JS, "Increasing survival of ischemic tissue by targeting CD47" 100 : 712-720, 2007

19 Stenina OI, "Increased expression of thrombospondin-1 in vessel wall of diabetic zucker rat" 107 : 3209-3215, 2003

20 Raman P, "Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells" 282 : 5704-5714, 2007

21 Poczatek MH, "Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1" 157 : 1353-1363, 2000

22 Bornstein P, "Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1" 130 : 503-506, 1995

23 Frangogiannis NG, "Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts" 111 : 2935-2942, 2005

24 Majack RA, "Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation" 106 : 415-422, 1988

25 Stouffer GA, "Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells" 97 : 907-915, 1998

26 Belmadani S, "A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II" 171 : 777-789, 2007

27 Baenziger NL, "A thrombin-sensitive protein of human platelet membranes" 68 : 240-243, 1971

28 Gensini GG, "A more meaningful scoring system for determining the severity of coronary heart disease" 51 : 606-, 1983